Search - tctmd.com

Displaying 121 - 140 of 147

Sort: Relevancy | Date

News Daily News

Mejor Respuesta al Clopidogrel a Mayores Niveles de Tabaquismo

Jason Kahn

March 21, 2012

News Daily News

Better Clopidogrel Response Seen with Increased Smoking Levels

Jason Kahn

March 21, 2012

Presentation

Puenteando la Terapia Antiplaquetaria con Cangrelor en Pacientes que se someten a Cirugía Cardíaca

Presenter: Dominick J. Angiolillo

January 16, 2012

Presentation

Bridging Antiplatelet Therapy with Cangrelor in Patients Undergoing Cardiac Surgery

Presenter: Dominick J. Angiolillo

January 16, 2012

News Daily News

BRIDGE Published: Cangrelor Promising Option as Bridging Therapy

January 16, 2012

Presentation TCT 2012

Transradial Approach To Coronary Interventions:How Steep Is The Learning Curve For Trained Interventional Cardiologists?

Presenter: Bharat Gummadi, Jeffrey R. Blackburn, Robert F. Percy, Lyndon C. Box, Dominick J. Angiolillo, Martin M. Zenni, Theodore A. Bass, Luis A. Guzman

January 03, 2012

News Conference News

BRIDGE: Cangrelor Provides Effective Maintenance of Platelet Inhibition Without Major Bleeding

November 09, 2011

News Industry News

Scripps Health and The Medicines Company Announce Late Breaking BRIDGE Trial Results Presented at TCT

November 08, 2011

News Industry News

Cangrelor provides effective maintenance of platelet inhibition without major bleeding for patients who require bypass surgery

November 08, 2011

News Daily News

Increased Clopidogrel Fails to Overcome High Platelet Reactivity

L.A. McKeown

September 20, 2011

News Conference News

GRAVITAS Analysis: Lower Cutpoint May Enhance Functional Platelet Testing

August 30, 2011

News Daily News

After Gravitas Part 2: Is There a Future for Functional Platelet Testing?

July 25, 2011

News Daily News

After GRAVITAS: Is There a Future for Functional Platelet Testing?

July 18, 2011

News Daily News

One-Month Platelet Reactivity After PCI Key Risk Factor for Future Events

June 13, 2011

News Daily News

Prasugrel Inhibits Platelet Function Better Than High-Dose Clopidogrel in Diabetics

Jason Kahn

January 26, 2011

Video

» On Record

On Record: Putting Post-PCI DAPT Into Perspective

June 11, 2025

Video

» Interview

Beyond the Data: The T-PASS Trial

November 6, 2023

CME

Aspirin for the Interventionalist: More Than Meets the Eye

CME

Advertisement

Mejor Respuesta al Clopidogrel a Mayores Niveles de Tabaquismo

Better Clopidogrel Response Seen with Increased Smoking Levels

Puenteando la Terapia Antiplaquetaria con Cangrelor en Pacientes que se someten a Cirugía Cardíaca

Bridging Antiplatelet Therapy with Cangrelor in Patients Undergoing Cardiac Surgery

BRIDGE Published: Cangrelor Promising Option as Bridging Therapy

Transradial Approach To Coronary Interventions:How Steep Is The Learning Curve For Trained Interventional Cardiologists?

BRIDGE: Cangrelor Provides Effective Maintenance of Platelet Inhibition Without Major Bleeding

Scripps Health and The Medicines Company Announce Late Breaking BRIDGE Trial Results Presented at TCT

Cangrelor provides effective maintenance of platelet inhibition without major bleeding for patients who require bypass surgery

Increased Clopidogrel Fails to Overcome High Platelet Reactivity

GRAVITAS Analysis: Lower Cutpoint May Enhance Functional Platelet Testing

After Gravitas Part 2: Is There a Future for Functional Platelet Testing?

After GRAVITAS: Is There a Future for Functional Platelet Testing?

One-Month Platelet Reactivity After PCI Key Risk Factor for Future Events

Prasugrel Inhibits Platelet Function Better Than High-Dose Clopidogrel in Diabetics

On Record: Putting Post-PCI DAPT Into Perspective

Beyond the Data: The T-PASS Trial

Aspirin for the Interventionalist: More Than Meets the Eye

Everyday Antiplatelet Decisions: Making the Right Choices

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content